(BPCA) Information Coordinating Center was funded below contract HHSN275201700002C (PI(BPCA) Data Coordinating Center was funded

(BPCA) Information Coordinating Center was funded below contract HHSN275201700002C (PI
(BPCA) Data Coordinating Center was funded beneath contract HHSN275201700002C (PI, Ravinder Anand). Y.S.S.W. was supported via a University of North Carolina (UNC)/Nuventra Pharmacokinetics/Pharmacodynamics Fellowship. M.C.-W. received support for study from the National Institutes of Well being (grants 1R01-HD076676-01A1 and 1K24-AI143971),July 2021 Volume 65 Concern 7 e02149-20 aac.asmWu et al.Antimicrobial Agents and Chemotherapythe National Dynamin site Institute of Allergy and Infectious Ailments (grants HHSN272201500006I and HHSN272201300017I), the National Institute of Youngster Well being and Human development (NICHD) (grant Urotensin Receptor Formulation HHSN275201000003I), the U.S. Meals and Drug Administration (grant 5U18FD006298), and sector for drug improvement in adults and children. C.P.H. received salary assistance for research from NICHD (grants 1K23HD090239 and R13HD102136), the National Heart Lung and Blood Institute (NHLBI) (grant R61/R33HL147833), and also the U.S. Meals and Drug Administration (grants 1R01-FD006099 [PI, Matthew Laughon] and 5U18-FD006298 [PI, Daniel K. Benjamin, Jr.]), and in the U.S. government for his perform in pediatric clinical pharmacology (contract HHSN275201800003I [PI, Daniel K. Benjamin, Jr.] under the best Pharmaceuticals for Children Act), from the nonprofit Burroughs Wellcome Fund, and from other sponsors for drug development in adults and young children (dcri/about-us/ conflict-of-interest/). J.G.G. received analysis help from the National Institute of Basic Health-related Sciences (NIGMS)-funded T32 system (award 5T32GM122741), as well as the American Foundation for Pharmaceutical Education (AFPE). D.G. received investigation assistance in the NICHD (grants K23HD083465 and R01HD096435). The content material is solely the responsibility from the authors and will not necessarily represent the official views in the National Institutes of Health. Y.S.S.W. and D.G. wrote the manuscript; Y.S.S.W. and D.G. designed the study; Y.S.S.W., M.C.-W., C.P.H., J.G.G., J.A., M.C., and D.G. performed the study; Y.S.S.W. and J.G.G. analyzed the data. PTN Steering Committee Members include Daniel K. Benjamin, Jr., Christoph Hornik, Kanecia Zimmerman, Phyllis Kennel, and Rose Beci, Duke Clinical Investigation Institute, Durham, NC; Chi Dang Hornik, Duke University Healthcare Center, Durham, NC; Gregory L. Kearns, Texas Christian University and UNTHSC School of Medicine, Fort Worth, TX; Matthew Laughon, University of North Carolina at Chapel Hill, Chapel Hill, NC; Ian M. Paul, Penn State College of Medicine, Hershey, PA; Janice Sullivan, University of Louisville, Louisville, KY; Kelly Wade, Children’s Hospital of Philadelphia, Philadelphia, PA; and Paula Delmore, Wichita Healthcare Investigation and Education Foundation, Wichita, KS. The Eunice Kennedy Shriver National Institute of Child Wellness and Human Development (NICHD) group members involve Perdita Taylor-Zapata and June Lee. The Emmes Organization, LLC (Data Coordinating Center), team members involve Ravinder Anand, Gaurav Sharma, Gina Simone, Kim Kaneshige, and Lawrence Taylor. The PTN Publications Committee is chaired by Thomas Green, Ann Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL. The Pediatric Trials Network trimethoprim-sulfamethoxazole POPS study team, principal investigators (PIs), and study coordinators (SCs) are as follows: at the Duke Clinical Analysis Institute, Tammy Day (clinical research associate [CRA]); in the Universitde Montr l, Julie Autmizguine (PI); in the University of North Carolina at Chapel Hill, Matthew.